Melanoma
Conference Coverage
Pembrolizumab for melanoma bittersweet, doctor says
“Until we can further define who the highest-risk patients are, I think it’s hard to give it to everyone,” one doctor says.
News
Quality of life benefit exaggerated in some cancer studies
Conference Coverage
Melanoma incidence is up, but death rates are down
“This is very encouraging data and represents the real-world effectiveness of these therapies.”
News
Evidence still lacking that vitamins prevent CVD, cancer: USPSTF
In its final recommendation statement on the subject, the task force does, however, recommend against use of vitamin E and beta-carotene.
Conference Coverage
Surgical site infections not increased in immunocompromised patients after Mohs surgery
Mohs surgery is increasingly being performed for patients who are immunosuppressed because of their higher incidence of skin cancer and higher...
Conference Coverage
Mohs surgery in the elderly: The dilemma of when to treat
“The take-home point for me is to treat your whole patient, not just the tumor.”
Conference Coverage
Bupivacaine following Mohs surgery reduces opioid use, study finds
Recent research has shown that Mohs micrographic surgeons have the highest rates of opioid prescribing of all dermatologists.
News
Experts urge stopping melanoma trial because of failure and harm
Immunotherapy combo fails in BRAF V60–mutated melanoma. Results suggest its time to abandon combination of PD-1/PD-L1 inhibitors with BRAF and MEK...
Opinion
Dodging potholes from cancer care to hospice transitions
The consequences of suboptimal hospice transitions can damage the mental health and well-being of patient and caregiver.
News
Q&A with Hubert (Hugh) Greenway, MD
“Every patient who comes to see me has a story, so I try to understand their story,” Dr. Hugh Greenway said.
